The absorption spectrum of aluminum phthalocyanine with a mean degree of sulfonation of 2.1 (AlPcS2), previously measured in vivo in a murine tumor model (L1210 leukemia), showed a significant (10 to 15 nm) red shift with respect to the spectrum in solution and in vitro. To investigate whether this behavior was due to the peculiar model considered (ascitic tumor), the absorption line shape was evaluated in vivo noninvasively in a solid tumor (murine MS-2 fibrosarcoma) by means of time-resolved reflectance. The spectrum acquired in the range of 650 to 695 nm after the injection of 2.5 or 5 mg/kg body weight AlPcS2 confirms the red shift to 680 to 685 nm. Experiments performed ex vivo suggest that the spectral shift is related to the interact...
The effect of systemic administration on drug uptake at cellular level was evaluated using time-gate...
Sulphonated phthalocyanines are studied as photosensitisers for photodynamic therapy of cancer. Thei...
Mice bearing the MS-2 fibrosarcoma were administered 0.25, 0.5 or 1 mg kg(-1) body weight (b.w.) of ...
The absorption spectrum of aluminum phthalocyanine with a mean degree of sulfonation of 2.1 (AlPcS 2...
The absorption spectrum of aluminum phthalocyanine with an average disulphonation of 2.1 (hereafter ...
The absorption spectrum of disulphonated Aluminum Phthalocyanine (AlS 2Pc) was measured in vivo in a...
The absorption spectrum of disulphonated Aluminum Phthalocyanine (AlS2Pc) was measured in vivo in a ...
Time-resolved reflectance spectroscopy was used to investigate the effects of photodynamic irradiati...
A system based on a femtosecond white-light continuum and a streak camera was used for recordings of...
The action spectrum of disulfonated aluminum phthalocyanine (AIS2-Pc) as a photosensitizer for photo...
Although the hematoporphyrin derivative (Hpd) is one of the most studied photosensitisers for photod...
Résumé: L'aluminium-phthalocyanine non sulfoné et sulfoné à divers degrés (AlCl-Pc, Al-PoSn) a été é...
Résumé: L'aluminium-phthalocyanine non sulfoné et sulfoné à divers degrés (AlCl-Pc, Al-PcSn) a été é...
Photosensitizer-induced fluorescence is studied as a technique for the detection of cancer, Therefor...
A fluorescence imaging system was used to monitor the emission of disulfonated aluminum phthalocyani...
The effect of systemic administration on drug uptake at cellular level was evaluated using time-gate...
Sulphonated phthalocyanines are studied as photosensitisers for photodynamic therapy of cancer. Thei...
Mice bearing the MS-2 fibrosarcoma were administered 0.25, 0.5 or 1 mg kg(-1) body weight (b.w.) of ...
The absorption spectrum of aluminum phthalocyanine with a mean degree of sulfonation of 2.1 (AlPcS 2...
The absorption spectrum of aluminum phthalocyanine with an average disulphonation of 2.1 (hereafter ...
The absorption spectrum of disulphonated Aluminum Phthalocyanine (AlS 2Pc) was measured in vivo in a...
The absorption spectrum of disulphonated Aluminum Phthalocyanine (AlS2Pc) was measured in vivo in a ...
Time-resolved reflectance spectroscopy was used to investigate the effects of photodynamic irradiati...
A system based on a femtosecond white-light continuum and a streak camera was used for recordings of...
The action spectrum of disulfonated aluminum phthalocyanine (AIS2-Pc) as a photosensitizer for photo...
Although the hematoporphyrin derivative (Hpd) is one of the most studied photosensitisers for photod...
Résumé: L'aluminium-phthalocyanine non sulfoné et sulfoné à divers degrés (AlCl-Pc, Al-PoSn) a été é...
Résumé: L'aluminium-phthalocyanine non sulfoné et sulfoné à divers degrés (AlCl-Pc, Al-PcSn) a été é...
Photosensitizer-induced fluorescence is studied as a technique for the detection of cancer, Therefor...
A fluorescence imaging system was used to monitor the emission of disulfonated aluminum phthalocyani...
The effect of systemic administration on drug uptake at cellular level was evaluated using time-gate...
Sulphonated phthalocyanines are studied as photosensitisers for photodynamic therapy of cancer. Thei...
Mice bearing the MS-2 fibrosarcoma were administered 0.25, 0.5 or 1 mg kg(-1) body weight (b.w.) of ...